Glazer Capital LLC’s SpringWorks Therapeutics SWTX Stock Holding History

Glazer Capital LLC’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,107,199	Closed	-$193M	–	338
2025 Q2	$193M	Buy	+4,107,199	New	+$183M	6.9%	2

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Glazer Capital LLC's SWTX Position: Q3 2025 in Review

Glazer Capital LLC sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,107,199 shares — an estimated $193M sold.

Glazer Capital LLC first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $193M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Glazer Capital LLC reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Glazer Capital LLC sold 4,107,199 SpringWorks Therapeutics shares in Q3 2025, an estimated $193M.
Glazer Capital LLC first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Glazer Capital LLC's SpringWorks Therapeutics position peaked at $193M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Glazer Capital LLC's 13F filing for Q3 2025, filed 13 Nov 2025.